Transplantation of normal isolated islets of langerhans for the treatment of diabetes remains an elusive goal in clinical practice. Perhaps the major problem preventing clinical islet transplantation has been limited by the inability to prevent islet allograft or xenograft rejection. Cyclosporin A is an immunosuppressive agent that improves survival of transplant. This exciting immunosuppressive agent was first used clinically in renal transplantation in 1978 (Ferguson and Fidlus 1982).The aim of this study was the isolation , purification and transplantation of hamster pancreatic islet as xenograft transplantation for the treatment of diabetic mice. It is also aimed to study the effect of cyclosporin A as an immunosuppressive agent on some biochemical parameters e.g blood glucose and blood insulin levels to induce maximum suppression of mice immune system and consequently realizing maximum survival of transplanted islets. A total of 30 streptozotocin induced mice were randomized to receive islets xenografts from golden syrian hamsters by three different approaches ,the first group of ten mice received islets only in the renal subcapsular space, the 2 nd of ten mice received islets in the renal subcapsular space and was given cyclosporin A in a dose of 15 mg/kg/day for three days.The 3 rd group of ten mice were received islets in the renal subcapsular space and were given cyclosporin A orally every day at a dose of 15 mg/kg/day for three days which was gradually decreased to 5 mg/kg/day. Non of the mice of group 1 became normoglycemic. All mice of group 2 became normoglycemic for 11±4 ( range 6-18 days) . only mice of group 3 enjoyed normoglycemic as long as cyclosporin-A was administrated. Consequantly, prolonged survival of islets xenografts may be achieved with administration of cyclosporin-A.
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Introduction:
Transplantation of normal isolated islets of langerhans for the treatment of diabetes remains an elusive goal in clinical practice. Perhaps the major problem in preventing clinical islet transplantation has been limited by the inability to prevent islet allograft or xenograft rejection. Various approaches and different sites have been suggested to prevent islet graft rejection and maintain long-term islet cell function (Lacy, 1983).
Immunosuppression by pharmacological agents such as cyclophosphamide, azathioprine and corticosteroids was of minor effectiveness. However, cyclosporin A (CyA) is a an immunosuppressive agent that improves survival of transplant. (Calne et.al ,1962) ). 
Fig (1). Structure of cyclosporine
Our study was conducted to evaluate the role of cyclosporin-A on the biochemical parameters such as blood glucose, Cylosporin A level in a trial to determine the minimum level of cyclosporin which cause maximum suppression of immune system and minimal nephrotoxicity to attain maximum survival of transplanted islets
Materials And Methods:-

Animals:
Golden Syrian hamsters, weighing 100-120 g were used as islet donors. Swiss mice were the recipients. Non fasting plasma glucose levels of the recipient mice were determined before the induction of diabetes. Blood sugar level was monitored via orbital sinus blood samples with Aqua trend sensor. The mice were made diabetic by a single intraperitoneal injection of streptozotocin (150 mg/ Kg body weight) and only those mice with serum glucose levels more than 350 mg/ dl were used for transplantation.
Islet Isolation:
Hamster islet was isolated according to the method previously described Getoh et al.,1985 and Avila et al., 2003 by intraduct injection of collagenase solution followed by digestion and extensive purification on Ficoll gradients. Hand-picked islets were cultured in CMRL-1066 medium containing 10% heat inactivated fetal calf serum (FCS) and antibiotic-antimycotic solution (1 ml/ 100 ml). The islets were then incubated at 37 C for 3 days in a humidified atmosphere of 5% CO 2 . Islets were stained for viability by diphenylthiocarbazone (DTZ).
In Vitro Insulin Secretion of Islets:
Insulin secretion in response to glucose was tested according to the method discribed by Gotoh et al, 1987. Freshly isolated or 24-hour cultured islets were incubated for 30 minutes at 37 C in a modified Krebs Ringer bicarbonate buffer containing 10 mM HBSS , 0.5 mM NaHCO 3 , 1mM CaCL 2 and 05% bovine serum albumin{KRB-HEPES,O PH 7.4} The basal KRB -HEPES used for incubation also contained low (2.8 mM) glucose or high {16.7 mM} glucose content . After incubation, the supernatant was immediately removed and stored separately at -20C until assayed for insulin content.
Transplantation of Islets:
At transplantation, Islets were maintained for 3-4 days and checked for viability by diphenyl thiocarbazone (DTZ) staining .Streptozotocin-induced diabetic mice were used as recipients with at least two consuctive blood glucose analysis of 350 mg/dl A total of 30 mice were divided into 3 different treatment groups. A small incision was made in the left lumber region to expose the left kidney. Countered islet were suspended in 0.3 ml CMRL-1066 medium and implanted underneath the renal capsule using 27 gouge needle without making an incision into the capsule. Each diabetic mice received a total of 10 islet per gram of body weight Cyclosporin-A treatment:-Group 2,3 were transplanted with islets and treated with Cyclosporin-A was adminsterated orally using stomach canula every day from the day of transplantation. The first dose was 15 mg/kg/day for three days (group 2), and 15mg/kg/day for three days gradually decreased to 5 mg/kg/day for one month (group3).
Post-transplantion Follow-up:
After transplantation, the mice were transferred to metabolic cages for daily examination. Non-fasting blood glucose levels of the recipients were monitored 3 times weekly for the first 3 weeks, then twice weekly thereafter. The mice were considered cured if exhibited the following criteria: a random plasma glucose less than 200 mg/ dl, a glucosuria with steady weight gain. Rejection was considered when blood sugar concentration exceeded 200 mg /dl on two consecutive bleedings.
Glucose Tolerance Test:
Glucose tolerance test was carried out in transplanted mice that maintained a normoglycemia state for at least 30 days as previously described (Iwata et al.,1994) . For comparison the glucose tolerance test was also performed with 5 normal nontransplanted mice and 5 diabetic non-transplanted mice. Glucose solution 1 mg/ kg body weight was infused endogastrically through a polyethylene tube into mice that had been fasted overnight. Blood glucose levels were determined at 0, 30, 60, 90 and 120 min of glucose injection. The results were expressed as average blood glucose level  SE. The degradation in glucose per minutes (k value) was calculated.
Determination of Cyclosporin A level:-
Cyclosporin A (CyA) was determined post-transplantation and after I week and 14 days according to the method of (Pesco etal , 1990) as follow:
Whole blood sample (150 L) , 50 L solublizing reagent and 300 L precipitating reagent (Supplemented in the CyA kit) were mixed together , vortex for 10 seconds and centrifuged for 5 minutes at 10900 rpm. The supernatant was then analyzed on the TDx analyzer using Cy A monoclonal whole blood kit . The Cyclosporin A level was obtained in ng/ml .
Where:-The constituents of the solublizing reagent are surfactant in water with 0.1% Sodium Azide as preservative . The constituents of the precipitating reagent are zinc sulphate solution in methanol and ethylene glycol.
Histological Examination
The grafts of transplanted mice were surgically removed at various intervals following transplant. the graft tissues were fixed in 10% formalin for 24 hours. dehydrated in a series of ethanol and transferred to xylene for two hours. After infiltration in paraffin at 60%C for one hour, the tissue was embedded in paraffin block until hardening. Sections of 4 µm were cut and routinely stained with haematoxylin.
Result
The mean number of islets obtained from one pancreas using 0.7 mg/ml collagenase type XI was 41448 islets. The islets were spherical or oval, some of them had exocrine tissue attached to their surface. Morphologically the cultured islets were characterized by golden brown with a distinct outer intact membrane Fig (2) . The insulin release from fresh islets compared with cultured islets in response to low (2.8 mM) and high (16.7 mM) glucose concentration is shown in fig  (3).   Fig (2) . The microscopic appearance of hamster isolated islets The result of islet transplantation are summarized in table 1. None of mice transplanted with islet only under the kidney capsule (Group 1) without administration of cyclosporin-A became normoglycemic. Mice receiving islets only in the renal subcapsular space and treated with cyclosporin-A 15 mg/kg/day for three days (Group 2) became normoglycemic for a mean of 11 ±4. on the other hand mice receiving islets only in the renal subcapsular space and treated with cyclosporin-A 15 mg/kg/day for three days. gradually decreased to 5 mg/kg/day for one month (group 3) became normoglycemic for a mean of 30 ± 6 and exhibit normoglycemia as long as cyclosporin-A was administrated. Kidney capsule Kidney capsule Kidney capsule 9,7,11,8,16,9,16.12,18  26,34,27,36.36,.24,29,32,29,26 ---------11 ± 4 30 ± 6
Glucose Tolerance Test:
Glucose tolerance tests were carried out in transplanted mice that had been maintained normoglycemic state for more than 30 days. Five mice from each group were infused with 1 g /kg glucose after 30 days of transplantation.The mice were able to normalize their blood glucose. In normal mice and mice transplanted with islet microcapsules,Plasma glucose peaked at 30 minutes. And returned to base line levels by 120 minutes. Diabetic mice showed higher glucose levels after 120 minutes. Compared to the normal mice with transplanted mice, there was no significant difference in blood glucose levels at 0,30,60,90 and 120 minutes, fig (4) . In the present study, the using inductal collagenase technique, approximately 414  48 intact islets of each adult rat pancreas. The viability of the isolated islets with this method were comparable with or even better than those in previous reports by others ( The insulin release from the islet gradually increased during 24 hours of culture, and the insulin content of cultured islets was relatively lower than that of freshly isolated (fig 10) . This in agreement with some previous reports by other investigators ( Lacy, et al., 1976; Robinovitsh, et al., 1978) . which showed that fresh islets isolated by conventional agitation with collagenase solution responded to a glucose stimulus immediately after isolation, and that responsiveness of the islets was better than that of the cultured islets and Gotoh, et al., 1987.
Islets of Langerhans have been considered extremely immunogenic sometimes surviving only for one or more days if transplanted across a strong histocompatibility barrier Barker,et al., 1980.
The data indicated that mice transplanted with islets under the kidney capsule and treated cyclosporine-A enjoy normoglycemia for a maximum eleven days , Moreover, a daily administration of cyclosporine-A causes the graft survival to be prolonged and enjoy normoglycemia as long as cyclosporin-A is given.
It is clear that the introduction of cyclosporin A (CyA) has resulted in significant improvement in transplant results and has external transplantation a routine procedures.The survival rate of islet transplantation xenografts was significantly improved under cyclosporin A immunosuppression, primarily due to the ability of this agent to prevent rejection of histocompatible grafts (Opelz, 1992).
It was suggested that CyA may either directly inhibits the function of unclear protiens critical to the T -lymphocytes activation (Ream, 1992) or may prevents the transduction of the mitogenic signal resulting from receptor ligation, to the nucleus at a stage after the rise in intracellular calcium levels (Angela, 1990 and Riesbeck et.al., 1994).CyA may also function as an immune inhibitor by imparing the ability of activated helper T -cells to respond to IL -2, probably by limiting interleukin -2-receptor (IL-2R) expression in which IL-2 is an essential cofactor in the activation of both cytotoxic T -lymphocytes and B -cells in acute rejection episodes (Winkelstein, 1994).
While cyclosporin A has remarkable immunosuppressive properties, it also produces acute nephrotoxicity which may be purely functional or both functional and morphological. This kidney toxicity represents a serious limitation to its use as an immunosuppressive agent, but the benefits of CyA clearly outweight the adverse effects of kidney (First, 1993 and Cardoso et al., 1996) .
In summary, It may concluded that , it is possible to create an immunoprivileged site under the kidney capsule in xenograft transplantation of pancreatic islet cells by administration of cyclosporine-A. It is hoped that the results of the present study could be applied to human of both sexes especially when the use of cyclosporine-A gave encouraging results. References:-
